Cetera Investment Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cetera Investment Advisers’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12M	Sell	48,515 -17,782	-27%	-$3.83M	0.01%	1037
2026 Q1	$13.3M	Buy	66,297 +3,427	+5%	+$709K	0.01%	904
2025 Q4	$13M	Buy	62,870 +10,064	+19%	+$2.01M	0.01%	880
2025 Q3	$9.47M	Buy	52,806 +7,390	+16%	+$1.26M	0.01%	1021
2025 Q2	$7.33M	Buy	45,416 +2,130	+5%	+$339K	0.01%	983
2025 Q1	$7.36M	Buy	+43,286	New	+$7.52M	0.01%	916
2024 Q3	–	Sell	-24,220	Closed	-$3.73M	–	3798
2024 Q2	$3.73M	Sell	24,220 -970	-4%	-$146K	0.01%	1164
2024 Q1	$3.87M	Buy	25,190 +19,271	+326%	+$2.94M	0.01%	1117
2023 Q4	$936K	Buy	5,919 +241	+4%	+$34.6K	0.01%	1138
2023 Q3	$831K	Sell	5,678 -406	-7%	-$61.9K	0.01%	1131
2023 Q2	$932K	Sell	6,084 -6,178	-50%	-$963K	0.01%	1095
2023 Q1	$1.9M	Buy	12,262 +7,957	+185%	+$1.25M	0.02%	753
2022 Q4	$664K	Sell	4,305 -245	-5%	-$36.1K	0.01%	1211
2022 Q3	$1K	Buy	4,550 +2,015	+79%	+$283K	﹤0.01%	1708
2022 Q2	$344K	Sell	2,535 -340	-12%	-$46.9K	0.01%	1328
2022 Q1	$429K	Sell	2,875 -643	-18%	-$95.1K	0.01%	1270
2021 Q4	$570K	Sell	3,518 -2,246	-39%	-$363K	0.01%	1107
2021 Q3	$957K	Sell	5,764 -798	-12%	-$136K	0.02%	788
2021 Q2	$1.13M	Sell	6,562 -1,143	-15%	-$189K	0.02%	730
2021 Q1	$1.24M	Sell	7,705 -11,754	-60%	-$2.01M	0.02%	582
2020 Q4	$3.27M	Buy	19,459 +9,576	+97%	+$1.55M	0.06%	309
2020 Q3	$1.55M	Buy	+9,883	New	+$1.62M	0.13%	190
2020 Q1	–	Sell	-5,411	Closed	-$807K	–	574
2019 Q4	$807K	Buy	5,411 +408	+8%	+$56K	0.08%	246
2019 Q3	$615K	Buy	5,003 +937	+23%	+$125K	0.07%	267
2019 Q2	$575K	Buy	4,066 +2,220	+120%	+$306K	0.07%	262
2019 Q1	$279K	Buy	+1,846	New	+$266K	0.04%	384
2018 Q4	–	Sell	-1,710	Closed	-$273K	–	469
2018 Q3	$273K	Buy	+1,710	New	+$259K	0.04%	387

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Cetera Investment Advisers's FBT Position: Q2 2026 in Review

Cetera Investment Advisers reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 27% in Q2 2026, selling an estimated $3.83M and leaving 48,515 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #1037.

Cetera Investment Advisers first reported a position in FBT in Q3 2018 and has held it in 27 quarters since. The position peaked at $13.3M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Cetera Investment Advisers held 48,515 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12M as of Q2 2026.
Cetera Investment Advisers sold 17,782 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.83M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1037 holding.
Cetera Investment Advisers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and has held it in 27 quarters since.
Cetera Investment Advisers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $13.3M in Q1 2026.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.